Related Experiment Video
Updated: May 29, 2026

10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Nanoparticle-Based Radiosensitization in Breast Cancer: A Multimodal Approach to Therapy and Immune Regulation.
Saleh A S AlAbdulhadi1, Ali A Majeed2, Djamila Polatova3
1Department Medical Laboratory Science, University Prince Sattam Bin Abdulaziz, Riyadh, Saudi Arabia.
Biotechnology Journal
|May 28, 2026
Summary
Nanoparticles enhance breast cancer radiotherapy by increasing tumor cell killing and reducing resistance. This approach improves treatment outcomes and minimizes side effects by targeting tumors and boosting immune responses.
Area of Science:
- Oncology
- Nanotechnology
- Radiotherapy
Background:
- Radiotherapy is crucial for breast cancer treatment but faces challenges due to tumor resistance, leading to recurrence.
- Nanoparticle-mediated radiosensitization offers a promising strategy to overcome these limitations.
Purpose of the Study:
- To review nanoparticle-mediated radiosensitization mechanisms for breast cancer.
- To explore novel approaches combining nanoparticles with natural compounds for enhanced radiosensitivity and reduced toxicity.
Main Methods:
- Metal nanoparticles (gold, silver, platinum, bismuth) enhance radiation dose and generate reactive oxygen species (ROS).
- Polymeric, liposomal, and hydrogel nanocarriers enable targeted delivery and sustained release of radiosensitizers.
- Nanoparticles inhibit DNA repair and modulate the tumor microenvironment to improve radiation response.
Main Results:
- Nanoparticles increase tumor cell cytotoxicity and reduce hypoxia-related radioresistance.
- Combination therapy with nanoparticles and natural compounds (curcumin, metformin) enhances radiosensitivity and oxidative stress.
- Nanoparticles can potentiate immunotherapy by activating immune cells and promoting anti-tumor memory.
Conclusions:
- Nanoparticle-mediated radiosensitization is a powerful strategy to improve breast cancer radiotherapy efficacy.
- Targeted delivery and combination therapies hold significant potential for better tumor control with reduced toxicity.

